PTPN11 and neoplasm: Deletion of SHP-2 in myeloid cells curbs B16 melanoma growth and boosts tumor concentrations of chemoattractant CXCL9, macrophage-produced IFNγ-induced CXCL9, and CD8+ T cell infiltration into tumors.